MetLife stock: Results due November 4 as JPMorgan targets USD 110 for MetLife stock
Published on 10/20/2026 at 16:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSReporting date and analyst target
- JPMorgan raised its MetLife target to USD 110.00 on October 15, 2026.
- MetLife will publish third-quarter 2026 results on November 4, 2026.
- MetLife stock costs EUR 89.43 at Lang & Schwarz on October 20, 2026 at 4:01 p.m. CEST.
- MetLife had a USD 63.7 billion market capitalization as of October 20, 2026.
MetLife Inc. stock (ISIN US59156R1086) has two dated reference points for investors: MarketBeat reported on October 15, 2026 that JPMorgan raised its price target from USD 108.00 to USD 110.00 and kept an overweight rating. MetLife stock was trading at EUR 89.43 at Lang & Schwarz on October 20, 2026 at 4:01 p.m. CEST.
Analyst target reaches USD 110.00
The JPMorgan change gives the latest analyst view a concrete level. Against MetLife's USD 100.30 NYSE price at 10:07 a.m. ET on October 20, 2026, the USD 110.00 target was 9.67 percent above the market price. The calculation uses the same US dollar basis and does not compare the target with the euro quotation.
The Stock Observer also reported the JPMorgan change and described the rating as overweight. Its cited analyst table included targets from USD 109.00 to USD 111.00 from other firms, while the most recent JPMorgan figure was USD 110.00.
Stock stays below its yearly high
MetLife's 52-week range was USD 67.33 to USD 102.43 as of October 20, 2026. The NYSE price of USD 100.30 therefore stood USD 2.13 below the high, while the Lang & Schwarz quotation provided the German investor view in euros.
The company had a USD 63.7 billion market capitalization as of October 20, 2026 and a trailing price-to-earnings ratio of 19.25. The current quotation was also above the 52-week low by USD 32.97, placing the stock much nearer the upper end of its yearly range than the lower end.
November 4 is the next date
MetLife will release its third-quarter 2026 financial results after the US market close on November 4, 2026, according to MetLife. The company scheduled its earnings call for November 5, 2026, from 9:00 a.m. to 10:00 a.m. ET. That date provides the next scheduled test for the earnings outlook behind the current analyst targets.
What the next report will test
The upcoming report matters because the current valuation combines a USD 19.25 trailing price-to-earnings ratio with a target of USD 110.00. The second-quarter 2026 revenue figure was USD 19.15 billion, while net income attributable to common shareholders was USD 705.0 million. These figures establish the latest reported operating scale before the November release.
MetLife stock and the next session
The euro quotation remains the key reference for investors trading through German venues, while the NYSE price and JPMorgan target are stated in US dollars. MetLife stock was trading at EUR 89.43 at Lang & Schwarz on October 20, 2026 at 4:01 p.m. CEST.
The further course of trading is shown by the continuously updated real-time quote of MetLife stock.
MetLife stock key data
- Company: MetLife, Inc.
- ISIN: US59156R1086
- Ticker: MET
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 20, 2026, 4:01 p.m. CEST): EUR 89.43
- Market capitalization: USD 63.7 billion (as of October 20, 2026)
- 52-week range: USD 67.33-102.43 (as of October 20, 2026)
- Sector / Industry: Financial Services / Insurance - Life
- Next earnings date: November 4, 2026
Market context: Market report S&P 500.
